H. Miles Prince MBBS (Hons) MD, MRACMA, FRACP, FRCPA
Director, Centre for Blood Cell Therapies
Peter MacCallum Cancer Centre
Melbourne, Victoria, Australia
Professor Miles Prince is Professor of Medicine at both Melbourne and Monash Universities and Director of the Centre for Blood Cell Therapies at the Peter MacCallum Cancer Centre, Melbourne.
He trained in Clinical and Laboratory Haematology in Melbourne and Sydney and completed his MD in Toronto, Canada examining gene transfer into myeloma cells for immunotherapy.
He has a very active research program involving clinical research and laboratory research – the latter involving stem cell research and cancer immunology. He has been involved in numerous clinical trials of new agents in myeloma and lymphoma including thalidomide, lenolidomide, bortezomib, VEGF inhibitors, retinoids, denileukin diftitox, monoclonal antibodies and histone deacetylase inhibitors.
He has published over 200 peer-reviewed manuscripts and 350+ abstracts/presentations, is a reviewer for numerous Journals, and a member of several Editorial Boards and Scientific Advisory Boards. He is the currently the Chairman of the Scientific Advisory Group to the Myeloma Foundation of Australia.
Video Interview with Miles Prince, recorded at the ICDO Summit 2009:
Audio Interview with Miles Prince, recorded at the ICDO Summit 2009: